Citrate-based dialysate chemical formulations
View Patent ↗The present invention constitutes dialysate formulations that are suitable for use in preparing dialysate solutions for use in batch and/or proportioning systems and for improving dialysis efficiency by reducing or preventing clotting of the dialysis flow paths. The dialysate chemical formulations for one batch of dialysate comprise an acid concentrate stored in a first vessel, and a citrate-containing bicarbonate concentrate stored in a second vessel. The contents of the first and second vessels are emptied into a dialysate preparation tank and mixed with water to form a batch quantity of dialysate solution. Alternately, a dry acid and/or a dry citrate-containing base concentrates are dissolved separately in measured quantities of water to form liquid concentrates which are then used in conjunction with a proportioning machine to generate on-line a final dialysis solution stream.
1. A kit for preparing a dialysis solution comprising:
(a) a container of a dry base concentrate comprising a citrate, a bicarbonate and a salt, wherein a sodium contribution of the dry base concentrate to the dialysate ranges from 100 to 150 mEq/L and a ratio of bicarbonate (mEq/L) to citrate (mEq/L) in the dry base concentrate ranges from 50:1 to 15:8; and
(b) a container of an acid concentrate comprising an acid selected from the group consisting of acetic acid, citric acid and lactic acid, wherein a sodium contribution of the acid concentrate to the dialysate ranges from 10 to 20 mEq/L,
wherein (i) the combination of the sodium contributions of the dry base concentrate and the acid concentrate to the dialysate ranges from 125 to 150 mEq/L, and (ii) the addition of base concentrate and acid concentrate to a prescribed volume of water produces a final volume of a dialysis solution.
2. The kit of claim 1 wherein said acid concentrate includes an acid selected from the group consisting of acetic acid, citric acid and lactic acid.
3. The kit of claim 1 wherein said salt is selected from the group consisting of sodium chloride, potassium chloride, calcium chloride and magnesium chloride.
4. The kit of claim 1 wherein said citrate is provided in a quantity to provide a final concentration in said dialysis solution from about 1 to about 8 mEq/L.
5. The kit of claim 1 wherein said bicarbonate is provided in a quantity to provide a final concentration in said dialysis solution from about 15 to about 50 mEq/L of said bicarbonate.
6. The kit of claim 1 wherein said salt is provided in a quantity to provide a final concentration in said dialysis solution from about 1.5 to about 150 mEq/L.
7. The kit of claim 1 wherein said acid in said acid concentrate is acetic acid, said acetic acid being provided in a quantity sufficient to provide a final concentration in said hemodialysate of between about 1 to about 8 mEq/L.
8. The kit of claim 1 wherein said citrate is selected from the group consisting of citric acid, a salt of citric anion, and a partial ester of citric anion.
9. The kit of claim 1 wherein said citrate is citric acid and said citric acid is separated from said bicarbonate.
10. The kit of claim 9 wherein the concentrate is contained in a vessel for preparation of a batch of dialysis solution for treatment of a single or multiple patients, or for a proportioning system for treatment of single or multiple patients, said salt is present as a layer deposited in the vessel between said citric acid and said bicarbonate.
11. The kit of claim 9 wherein said citric acid in the base concentrate is in the form of tablets.
12. The kit of claim 11 wherein the tablets are coated with dextrose or sodium chloride.
13. The kit of claim 9 wherein said citrate is trisodium citrate, disodium hydrogen citrate or monosodium dihydrogen citrate.
14. The kit of claim 13 wherein the concentrate is contained in a vessel for preparation of a batch of dialysis solution for treatment of a single or multiple patients or for a proportioning system for treatment of single or multiple patients said sodium citrate, bicarbonate, and salt are evenly mixed in the vessel.
15. The kit of claim 9 wherein the acid and base concentrates are used to prepare a hemodialysis concentrate and final solution.